Anzeige
Mehr »
Donnerstag, 23.04.2026 - Börsentäglich über 12.000 News
Diese Aktie zündet die nächste Explorationsstufe - und der Markt beginnt aufzuwachen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16.04.Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
16.04.Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
16.04.Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
15.04.In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
15.04.Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
15.04.Novartis CEO Vas Narasimhan joins Anthropic's board as biopharma's ties to AI deepen
15.04.Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
15.04.Teva launches new online schizophrenia community project
15.04.Pfizer recruits former Angel Lucy Liu for latest mission against cancer
15.04.Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
14.04.FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
14.04.J&J, chasing $100B year, sports immunology 'dual powerhouse' of Tremfya and new launch Icotyde
14.04.Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
14.04.Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
13.04.Lilly's Jaypirca shows fixed-duration power in 'ambitious' phase 3 CLL trial win
13.04.ViiV launches 'Still Here' campaign aimed at reminding younger people about HIV
10.04.HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety
10.04.Charles River flows into Boston to help AHA bridge cardiovascular health divide
10.04.Starting material sourcing bottlenecks increase US drug shortage risks: report
10.04.Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on
10.04.Envision hires ConcertAI, IQVIA alum Nick Jones as its med comms president
10.04.The top 10 pharma R&D budgets of 2025
10.04.Bial launches 'Dialogues with Parkinson's' campaign aimed at identifying early symptoms
10.04.Abbott survey finds 'information overload, confusion and cost' affecting health choices in US
10.04.FDA accuses Amneal, BioCorRx of producing 'false and misleading' drug promos